These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


190 related items for PubMed ID: 2262892

  • 21. Pharmacological comparison of two corticotropin-releasing factor antagonists: in vivo and in vitro studies.
    Curtis AL, Grigoriadis DE, Page ME, Rivier J, Valentino RJ.
    J Pharmacol Exp Ther; 1994 Jan; 268(1):359-65. PubMed ID: 8301577
    [Abstract] [Full Text] [Related]

  • 22. A study of the lasting effects of cocaine pre-exposure on anxiety-like behaviors under baseline conditions and in response to central injections of corticotropin-releasing factor.
    Erb S, Kayyali H, Romero K.
    Pharmacol Biochem Behav; 2006 Sep; 85(1):206-13. PubMed ID: 16987545
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Norepinephrine but not epinephrine stimulates the release of corticotropin-releasing factor from in vitro superfused rat hypothalamus.
    Orliaguet G, Mélik Parsadaniantz S, Lenoir V, Duval P, Kerdelhué B.
    J Neurosci Res; 1995 Oct 01; 42(2):236-41. PubMed ID: 8568924
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.
    de Groote L, Peñalva RG, Flachskamm C, Reul JM, Linthorst AC.
    J Neurochem; 2005 Jul 01; 94(1):45-56. PubMed ID: 15953348
    [Abstract] [Full Text] [Related]

  • 28. Effects of systemic and intracerebroventricular phenylephrine and clonidine on corticosterone secretion in rats.
    Gadek-Michalska A, Turoń M, Bugajski J, Połczyńska-Konior G.
    Endocrinol Exp; 1990 Mar 01; 24(1-2):249-58. PubMed ID: 2361464
    [Abstract] [Full Text] [Related]

  • 29. Effects of prenatal stress on defensive withdrawal behavior and corticotropin releasing factor systems in rat brain.
    Ward HE, Johnson EA, Salm AK, Birkle DL.
    Physiol Behav; 2000 Mar 01; 70(3-4):359-66. PubMed ID: 11006435
    [Abstract] [Full Text] [Related]

  • 30. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
    Menzaghi F, Howard RL, Heinrichs SC, Vale W, Rivier J, Koob GF.
    J Pharmacol Exp Ther; 1994 May 01; 269(2):564-72. PubMed ID: 8182523
    [Abstract] [Full Text] [Related]

  • 31. Hyperactivity of central noradrenergic and CRF systems is involved in social isolation-induced decrease in pentobarbital sleep.
    Ojima K, Matsumoto K, Tohda M, Watanabe H.
    Brain Res; 1995 Jun 26; 684(1):87-94. PubMed ID: 7583209
    [Abstract] [Full Text] [Related]

  • 32. Secretion of corticotropin-releasing factor from cultured rat hypothalamic cells: effects of catecholamines.
    Widmaier EP, Lim AT, Vale W.
    Endocrinology; 1989 Feb 26; 124(2):583-90. PubMed ID: 2783568
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Role of brain nicotinic acetylcholine receptor in centrally administered corticotropin-releasing factor-induced elevation of plasma corticosterone in rats.
    Okada S, Yamaguchi-Shima N, Shimizu T, Arai J, Lianyi L, Wakiguchi H, Yokotani K.
    Eur J Pharmacol; 2008 Jun 10; 587(1-3):322-9. PubMed ID: 18423439
    [Abstract] [Full Text] [Related]

  • 35. Corticotropin-releasing factor receptor antagonist infused into the locus coeruleus attenuates immobilization stress-induced defensive withdrawal in rats.
    Smagin GN, Harris RB, Ryan DH.
    Neurosci Lett; 1996 Dec 20; 220(3):167-70. PubMed ID: 8994219
    [Abstract] [Full Text] [Related]

  • 36. Reduction of exploratory behavior by intraperitoneal injection of interleukin-1 involves brain corticotropin-releasing factor.
    Dunn AJ, Antoon M, Chapman Y.
    Brain Res Bull; 1991 Apr 20; 26(4):539-42. PubMed ID: 1868353
    [Abstract] [Full Text] [Related]

  • 37. Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor.
    Valentino RJ, Page ME, Curtis AL.
    Brain Res; 1991 Jul 26; 555(1):25-34. PubMed ID: 1933327
    [Abstract] [Full Text] [Related]

  • 38. Hypothalamic corticotrophin-releasing factor and norepinephrine mediate sympathetic and cardiovascular responses to acute intracarotid injection of tumour necrosis factor-alpha in the rat.
    Zhang ZH, Felder RB.
    J Neuroendocrinol; 2008 Aug 26; 20(8):978-87. PubMed ID: 18777604
    [Abstract] [Full Text] [Related]

  • 39. Common mechanisms underlying the proconflict effects of corticotropin-releasing factor, a benzodiazepine inverse agonist and electric foot-shock.
    De Boer SF, Katz JL, Valentino RJ.
    J Pharmacol Exp Ther; 1992 Jul 26; 262(1):335-42. PubMed ID: 1625207
    [Abstract] [Full Text] [Related]

  • 40. Effect of corticotropin-releasing factor antagonist on behavioral and neuroendocrine responses during exposure to defensive burying paradigm in rats.
    Korte SM, Korte-Bouws GA, Bohus B, Koob GF.
    Physiol Behav; 1994 Jul 26; 56(1):115-20. PubMed ID: 8084889
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.